{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:17:58Z","timestamp":1778505478119,"version":"3.51.4"},"reference-count":157,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,5]],"date-time":"2027-02-05T00:00:00Z","timestamp":1801785600000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["U19AI167891"],"award-info":[{"award-number":["U19AI167891"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["U19AI142733"],"award-info":[{"award-number":["U19AI142733"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["R01HL149676"],"award-info":[{"award-number":["R01HL149676"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["CFF003379122"],"award-info":[{"award-number":["CFF003379122"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["CFF004416AB322"],"award-info":[{"award-number":["CFF004416AB322"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["CFF003753AB322"],"award-info":[{"award-number":["CFF003753AB322"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL169265"],"award-info":[{"award-number":["R01 HL169265"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL152083"],"award-info":[{"award-number":["R01 HL152083"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL149676"],"award-info":[{"award-number":["R01HL149676"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI142733"],"award-info":[{"award-number":["U19AI142733"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI167891"],"award-info":[{"award-number":["U19AI167891"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ccm.2025.11.003","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T20:22:22Z","timestamp":1767126142000},"page":"67-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunology of Sepsis"],"prefix":"10.1016","volume":"47","author":[{"given":"Eric D.","family":"Morrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Mikacenic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ccm.2025.11.003_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"15","key":"10.1016\/j.ccm.2025.11.003_bib3","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and outcomes of infection among patients in intensive care units in 2017","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ccm.2025.11.003_bib4","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1164\/rccm.201310-1875OC","article-title":"Association between source of infection and hospital mortality in patients who have septic shock","volume":"189","author":"Leligdowicz","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41577-018-0084-5","article-title":"The immunological anatomy of the skin","volume":"19","author":"Kabashima","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.003_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000336619","article-title":"\u03b2-Defensins: multifunctional modulators of infection, inflammation and more?","volume":"4","author":"Semple","year":"2012","journal-title":"J Innate Immun"},{"issue":"10","key":"10.1016\/j.ccm.2025.11.003_bib7","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.ccm.2025.11.003_bib8","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.4049\/jimmunol.147.12.4155","article-title":"Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified Ia+ keratinocytes","volume":"147","author":"Gaspari","year":"1991","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.003_bib9","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.4049\/jimmunol.150.6.2148","article-title":"Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1\/intercellular adhesion molecule-1 interaction","volume":"150","author":"Nickoloff","year":"1993","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.ccm.2025.11.003_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41579-023-00865-7","article-title":"Pathogenesis, epidemiology and control of group A streptococcus infection","volume":"21","author":"Brouwer","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"10.1016\/j.ccm.2025.11.003_bib11","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jamasurg.2024.3365","article-title":"Necrotizing soft tissue infections: a review","volume":"159","author":"McDermott","year":"2024","journal-title":"JAMA Surg"},{"issue":"23","key":"10.1016\/j.ccm.2025.11.003_bib12","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1056\/NEJMra1600673","article-title":"Necrotizing soft-tissue infections","volume":"377","author":"Stevens","year":"2017","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ccm.2025.11.003_bib13","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa042683","article-title":"Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles","volume":"352","author":"Miller","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.003_bib14","first-page":"680","article-title":"Risk factors for necrotizing fasciitis and its outcome at A tertiary care centre","volume":"28","author":"Gupta","year":"2016","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"10.1016\/j.ccm.2025.11.003_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1034\/j.1600-065X.2000.917304.x","article-title":"The innate immune response of the respiratory epithelium","volume":"173","author":"Diamond","year":"2000","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.003_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41577-020-00477-9","article-title":"Regulation of immune responses by the airway epithelial cell landscape","volume":"21","author":"Hewitt","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1165\/rcmb.2011-0289OC","article-title":"LPS-stimulated cytokine production in type I cells is modulated by the renin\u2013angiotensin system","volume":"46","author":"Wong","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib18","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.4049\/jimmunol.1200634","article-title":"Type I alveolar epithelial cells mount innate immune responses during pneumococcal pneumonia","volume":"189","author":"Yamamoto","year":"2012","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.003_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1165\/rcmb.2004-0078OC","article-title":"Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells","volume":"31","author":"Armstrong","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(03)00758-X","article-title":"By binding SIRPalpha or calreticulin\/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation","volume":"115","author":"Gardai","year":"2003","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.003_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/infdis\/172.2.481","article-title":"Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages","volume":"172","author":"Pikaar","year":"1995","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.ccm.2025.11.003_bib22","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.4049\/jimmunol.167.10.5868","article-title":"Surfactant protein D enhances clearance of influenza A virus from the lung in vivo","volume":"167","author":"LeVine","year":"2001","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.ccm.2025.11.003_bib23","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1172\/JCI5849","article-title":"Surfactant protein-A enhances respiratory syncytial virus clearance in vivo","volume":"103","author":"LeVine","year":"1999","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12931-023-02657-2","article-title":"The complement cascade in lung injury and disease","volume":"25","author":"Detsika","year":"2024","journal-title":"Respir Res"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib25","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI113472","article-title":"Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways","volume":"81","author":"Strunk","year":"1988","journal-title":"J Clin Investig"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib26","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41385-022-00534-7","article-title":"A single-cell lung atlas of complement genes identifies the mesothelium and epithelium as prominent sources of extrahepatic complement proteins","volume":"15","author":"Chaudhary","year":"2022","journal-title":"Mucosal Immunol"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.003_bib27","first-page":"415","article-title":"Secretion of complement components of the alternative pathway (C3 and factor B) by the human alveolar type II epithelial cell line A549","volume":"5","author":"Zhao","year":"2000","journal-title":"Int J Mol Med"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib28","doi-asserted-by":"crossref","first-page":"L790","DOI":"10.1152\/ajplung.2000.279.5.L790","article-title":"Complement-mediated host defense in the lung","volume":"279","author":"Watford","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"14","key":"10.1016\/j.ccm.2025.11.003_bib29","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.molimm.2011.05.001","article-title":"Complement deficiency states and associated infections","volume":"48","author":"Skattum","year":"2011","journal-title":"Mol Immunol"},{"issue":"10","key":"10.1016\/j.ccm.2025.11.003_bib30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nri3887","article-title":"The nature of immune responses to urinary tract infections","volume":"15","author":"Abraham","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.003_bib31","doi-asserted-by":"crossref","first-page":"F795","DOI":"10.1152\/ajprenal.00357.2003","article-title":"Ablation of the tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli","volume":"286","author":"Mo","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.003_bib32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1523-1755.2004.00452.x","article-title":"Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication","volume":"65","author":"Bates","year":"2004","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nm1572","article-title":"Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells","volume":"13","author":"Bishop","year":"2007","journal-title":"Nat Med"},{"issue":"35","key":"10.1016\/j.ccm.2025.11.003_bib34","doi-asserted-by":"crossref","first-page":"14966","DOI":"10.1073\/pnas.0900527106","article-title":"TLR4-mediated expulsion of bacteria from infected bladder epithelial cells","volume":"106","author":"Song","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.003_bib35","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.cell.2015.05.009","article-title":"A TRP channel senses lysosome neutralization by pathogens to trigger their expulsion","volume":"161","author":"Miao","year":"2015","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chom.2009.04.005","article-title":"Bone morphogenetic protein 4 signaling regulates epithelial renewal in the urinary tract in response to uropathogenic infection","volume":"5","author":"Mysorekar","year":"2009","journal-title":"Cell Host Microbe"},{"issue":"5393","key":"10.1016\/j.ccm.2025.11.003_bib37","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1126\/science.282.5393.1494","article-title":"Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli","volume":"282","author":"Mulvey","year":"1998","journal-title":"Science"},{"issue":"7341","key":"10.1016\/j.ccm.2025.11.003_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature09851","article-title":"Hedgehog\/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder","volume":"472","author":"Shin","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.UTI-0003-2012","article-title":"Urosepsis: overview of the diagnostic and treatment challenges","volume":"3","author":"Wagenlehner","year":"2015","journal-title":"Microbiol Spectr"},{"issue":"8","key":"10.1016\/j.ccm.2025.11.003_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001042","article-title":"Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection","volume":"6","author":"Hannan","year":"2010","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.003_bib41","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nri.2016.49","article-title":"Neutrophil migration in infection and wound repair: going forward in reverse","volume":"16","author":"de Oliveira","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ccm.2025.11.003_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-pathmechdis-051222-015009","article-title":"Neutrophils in physiology and pathology","volume":"19","author":"Aroca-Crevill\u00e9n","year":"2024","journal-title":"Annu Rev Pathol"},{"issue":"9","key":"10.1016\/j.ccm.2025.11.003_bib43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/s41590-020-0736-z","article-title":"Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection","volume":"21","author":"Xie","year":"2020","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1164\/rccm.202104-1027OC","article-title":"Two new neutrophil subsets define a discriminating sepsis signature","volume":"205","author":"Meghraoui-Kheddar","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib45","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41590-023-01490-5","article-title":"Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis","volume":"24","author":"Kwok","year":"2023","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.ccm.2025.11.003_bib46","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.2020009417","article-title":"Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis","volume":"138","author":"Wang","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.003_bib47","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1189\/jlb.4HI0616-255R","article-title":"Frontline science: defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1","volume":"100","author":"Patera","year":"2016","journal-title":"J Leukoc Biol"},{"issue":"7810","key":"10.1016\/j.ccm.2025.11.003_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-020-2227-7","article-title":"Mouse models of neutropenia reveal progenitor-stage-specific defects","volume":"582","author":"Muench","year":"2020","journal-title":"Nature"},{"issue":"7309","key":"10.1016\/j.ccm.2025.11.003_bib49","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib50","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/s41467-021-22973-9","article-title":"The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments","volume":"12","author":"Grieshaber-Bouyer","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.003_bib51","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4049\/jimmunol.2200154","article-title":"Single-cell analysis reveals the range of transcriptional states of circulating human neutrophils","volume":"209","author":"Wigerblad","year":"2022","journal-title":"J Immunol"},{"key":"10.1016\/j.ccm.2025.11.003_bib52","article-title":"Dysregulation of neutrophil death in sepsis","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ccm.2025.11.003_bib53","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1084\/jem.20181468","article-title":"Neutrophils instruct homeostatic and pathological states in naive tissues","volume":"215","author":"Casanova-Acebes","year":"2018","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib54","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2020.10.003","article-title":"Co-option of neutrophil fates by tissue environments","volume":"183","author":"Ballesteros","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.003_bib55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.ccm.2025.11.003_bib56","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ni.2987","article-title":"Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens","volume":"15","author":"Branzk","year":"2014","journal-title":"Nat Immunol"},{"issue":"13","key":"10.1016\/j.ccm.2025.11.003_bib57","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood-2009-05-221606","article-title":"Restoration of NET formation by gene therapy in CGD controls aspergillosis","volume":"114","author":"Bianchi","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ccm.2025.11.003_bib58","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1172\/JCI76009","article-title":"Papillon-Lef\u00e8vre syndrome patient reveals species-dependent requirements for neutrophil defenses","volume":"124","author":"S\u00f8rensen","year":"2014","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40635-014-0021-2","article-title":"Neutrophil extracellular traps in the host defense against sepsis induced by Burkholderia pseudomallei (melioidosis)","volume":"2","author":"de Jong","year":"2014","journal-title":"Intensive Care Med Exp"},{"issue":"9","key":"10.1016\/j.ccm.2025.11.003_bib60","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/nm.2847","article-title":"Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo","volume":"18","author":"Yipp","year":"2012","journal-title":"Nat Med"},{"issue":"6160","key":"10.1016\/j.ccm.2025.11.003_bib61","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1126\/science.1242255","article-title":"Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death","volume":"342","author":"Thammavongsa","year":"2013","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ccm.2025.11.003_bib62","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20100239","article-title":"PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps","volume":"207","author":"Li","year":"2010","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.ccm.2025.11.003_bib63","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1182\/blood-2014-07-587709","article-title":"PAD4-deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shock","volume":"125","author":"Martinod","year":"2015","journal-title":"Blood"},{"issue":"36","key":"10.1016\/j.ccm.2025.11.003_bib64","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.ccm.2025.11.003_bib65","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2016-09-741298","article-title":"Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2025.11.003_bib66","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1038\/ncomms7673","article-title":"Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature","volume":"6","author":"Kolaczkowska","year":"2015","journal-title":"Nat Commun"},{"issue":"9530","key":"10.1016\/j.ccm.2025.11.003_bib67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(06)69005-3","article-title":"Neutrophils in development of multiple organ failure in sepsis","volume":"368","author":"Brown","year":"2006","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ccm.2025.11.003_bib68","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jama.1995.03530120060042","article-title":"Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU group for severe sepsis","volume":"274","author":"Brun-Buisson","year":"1995","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.ccm.2025.11.003_bib69","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.2016.2691","article-title":"Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis","volume":"315","author":"van Vught","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ccm.2025.11.003_bib70","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41577-023-00848-y","article-title":"Tissue-specific macrophages: how they develop and choreograph tissue biology","volume":"23","author":"Mass","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"16","key":"10.1016\/j.ccm.2025.11.003_bib71","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ccm.2025.11.003_bib72","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1084\/jem.20170355","article-title":"The fate and lifespan of human monocyte subsets in steady state and systemic inflammation","volume":"214","author":"Patel","year":"2017","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.ccm.2025.11.003_bib73","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1182\/blood.V82.10.3170.3170","article-title":"The novel subset of CD14+\/CD16+ blood monocytes is expanded in sepsis patients","volume":"82","author":"Fingerle","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2025.11.003_bib74","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-immunol-042617-053119","article-title":"Nonclassical monocytes in health and disease","volume":"37","author":"Narasimhan","year":"2019","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"10.1016\/j.ccm.2025.11.003_bib75","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00134-010-1962-x","article-title":"Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock","volume":"36","author":"Landelle","year":"2010","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.003_bib76","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm0697-678","article-title":"Monocyte deactivation in septic patients: restoration by IFN-gamma treatment","volume":"3","author":"D\u00f6cke","year":"1997","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.003_bib77","doi-asserted-by":"crossref","DOI":"10.1186\/cc13150","article-title":"Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock","volume":"17","author":"Cazalis","year":"2013","journal-title":"Crit Care"},{"issue":"23","key":"10.1016\/j.ccm.2025.11.003_bib78","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib79","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/cc13176","article-title":"Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis","volume":"18","author":"Chang","year":"2014","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib80","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/cc10059","article-title":"Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients","volume":"15","author":"Zhang","year":"2011","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.003_bib81","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/cc10112","article-title":"Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients","volume":"15","author":"Guignant","year":"2011","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.003_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/cc12711","article-title":"Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis","volume":"17","author":"Chang","year":"2013","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib83","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/SHK.0b013e3182168cce","article-title":"Dose-dependent effect of anti-CTLA-4 on survival in sepsis","volume":"36","author":"Inoue","year":"2011","journal-title":"Shock"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.003_bib84","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cell.2014.11.018","article-title":"Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment","volume":"159","author":"Lavin","year":"2014","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ccm.2025.11.003_bib85","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/nm.4430","article-title":"Barrier-tissue macrophages: functional adaptation to environmental challenges","volume":"23","author":"Mowat","year":"2017","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.003_bib86","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/mi.2012.89","article-title":"Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors","volume":"6","author":"Bain","year":"2013","journal-title":"Mucosal Immunol"},{"issue":"12","key":"10.1016\/j.ccm.2025.11.003_bib87","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1002\/eji.201242847","article-title":"CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis","volume":"42","author":"Tamoutounour","year":"2012","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.003_bib88","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/eji.201040965","article-title":"CX3CR1 defines functionally distinct intestinal mononuclear phagocyte subsets which maintain their respective functions during homeostatic and inflammatory conditions","volume":"41","author":"Weber","year":"2011","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib89","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.immuni.2014.03.012","article-title":"Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis","volume":"40","author":"Zigmond","year":"2014","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.003_bib90","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/mi.2015.65","article-title":"CD11c(+) monocyte\/macrophages promote chronic Helicobacter hepaticus-induced intestinal inflammation through the production of IL-23","volume":"9","author":"Arnold","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.003_bib91","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1165\/rcmb.2017-0061OC","article-title":"Cell origin dictates programming of resident versus recruited macrophages during acute lung injury","volume":"57","author":"Mould","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"8","key":"10.1016\/j.ccm.2025.11.003_bib92","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1084\/jem.20162152","article-title":"Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span","volume":"214","author":"Misharin","year":"2017","journal-title":"J Exp Med"},{"issue":"73","key":"10.1016\/j.ccm.2025.11.003_bib93","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj5761","article-title":"Monocyte-derived alveolar macrophages autonomously determine severe outcome of respiratory viral infection","volume":"7","author":"Li","year":"2022","journal-title":"Sci Immunol"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.003_bib94","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41590-019-0568-x","article-title":"Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection","volume":"21","author":"Aegerter","year":"2020","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib95","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150239","article-title":"Recruitment and training of alveolar macrophages after pneumococcal pneumonia","volume":"7","author":"Arafa","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib96","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1038\/s41467-023-43223-0","article-title":"The transcriptional and phenotypic characteristics that define alveolar macrophage subsets in acute hypoxemic respiratory failure","volume":"14","author":"Morrell","year":"2023","journal-title":"Nat Commun"},{"issue":"33","key":"10.1016\/j.ccm.2025.11.003_bib97","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1073\/pnas.1705365114","article-title":"Mouse macrophages show different requirements for phosphatidylserine receptor Tim4 in efferocytosis","volume":"114","author":"Yanagihashi","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib98","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1084\/jem.20161375","article-title":"Phagocytosis imprints heterogeneity in tissue-resident macrophages","volume":"214","author":"A-Gonzalez","year":"2017","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib99","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41590-018-0249-1","article-title":"DEL-1 promotes macrophage efferocytosis and clearance of inflammation","volume":"20","author":"Kourtzelis","year":"2019","journal-title":"Nat Immunol"},{"issue":"6284","key":"10.1016\/j.ccm.2025.11.003_bib100","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"issue":"7147","key":"10.1016\/j.ccm.2025.11.003_bib101","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/nature05836","article-title":"Gene-specific control of inflammation by TLR-induced chromatin modifications","volume":"447","author":"Foster","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.003_bib102","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cell.2007.08.019","article-title":"The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing","volume":"130","author":"De Santa","year":"2007","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.003_bib103","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41591-020-0752-4","article-title":"An immune-cell signature of bacterial sepsis","volume":"26","author":"Reyes","year":"2020","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.003_bib104","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41590-020-0673-x","article-title":"Alveolar macrophages are epigenetically altered after inflammation, leading to long-term lung immunoparalysis","volume":"21","author":"Roquilly","year":"2020","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.ccm.2025.11.003_bib105","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1161\/ATVBAHA.119.312754","article-title":"Sepsis induces prolonged epigenetic modifications in bone marrow and peripheral macrophages impairing inflammation and wound healing","volume":"39","author":"Davis","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib106","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.4049\/jimmunol.166.5.3599","article-title":"IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans","volume":"166","author":"Verbon","year":"2001","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib107","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/SHK.0000000000000234","article-title":"Persistent lymphopenia after diagnosis of sepsis predicts mortality","volume":"42","author":"Drewry","year":"2014","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.003_bib108","doi-asserted-by":"crossref","first-page":"420","DOI":"10.5603\/FHC.2012.0057","article-title":"Absolute counts of peripheral blood leukocyte subpopulations in intraabdominal sepsis and pneumonia-derived sepsis: a pilot study","volume":"50","author":"Hoser","year":"2012","journal-title":"Folia Histochem Cytobiol"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.003_bib109","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/CCM.0b013e318274645f","article-title":"Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly","volume":"41","author":"Inoue","year":"2013","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib110","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/520307","article-title":"High incidence of active cytomegalovirus infection among septic patients","volume":"26","author":"Kutza","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.003_bib111","article-title":"Reactivation of multiple viruses in patients with sepsis","volume":"9","author":"Walton","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib112","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/CCM.0b013e3182657948","article-title":"Decreased T-cell repertoire diversity in sepsis: a preliminary study","volume":"41","author":"Venet","year":"2013","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169653","article-title":"Increased PD-1 expression and altered T cell repertoire diversity predict mortality in patients with septic shock: a preliminary Study","volume":"12","author":"Tomino","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib114","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/clim.2000.4879","article-title":"Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunodepression","volume":"96","author":"De","year":"2000","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.003_bib115","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4049\/jimmunol.1401711","article-title":"Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge","volume":"194","author":"Cabrera-Perez","year":"2015","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.003_bib116","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/eji.200939739","article-title":"Impaired CD4+ T-cell proliferation and effector function correlates with repressive histone methylation events in a mouse model of severe sepsis","volume":"40","author":"Carson","year":"2010","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.ccm.2025.11.003_bib117","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1097\/01.CCM.0000145999.42971.4B","article-title":"Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes","volume":"32","author":"Venet","year":"2004","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.ccm.2025.11.003_bib118","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1097\/01.CCM.0000069345.78884.0F","article-title":"Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis","volume":"31","author":"Monneret","year":"2003","journal-title":"Crit Care Med"},{"issue":"22","key":"10.1016\/j.ccm.2025.11.003_bib119","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1182\/blood-2009-09-241083","article-title":"The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth","volume":"115","author":"Cavassani","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib120","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41590-024-01819-8","article-title":"Sepsis-trained macrophages promote antitumoral tissue-resident T cells","volume":"25","author":"Broquet","year":"2024","journal-title":"Nat Immunol"},{"issue":"23","key":"10.1016\/j.ccm.2025.11.003_bib121","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1001\/jama.2011.1853","article-title":"The search for effective therapy for sepsis: back to the drawing board?","volume":"306","author":"Angus","year":"2011","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.ccm.2025.11.003_bib122","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1001\/jama.1994.03510470040032","article-title":"Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group","volume":"271","author":"Fisher","year":"1994","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib123","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/CCM.0000000000002749","article-title":"Mortality benefit of recombinant human Interleukin-1 receptor antagonist for sepsis varies by initial Interleukin-1 receptor antagonist plasma concentration","volume":"46","author":"Meyer","year":"2018","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.ccm.2025.11.003_bib124","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib126","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003536","article-title":"Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomised controlled clinical trial","volume":"4","author":"Livigni","year":"2014","journal-title":"BMJ Open"},{"issue":"14","key":"10.1016\/j.ccm.2025.11.003_bib127","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2018.14618","article-title":"Effect of targeted polymyxin B hemoperfusion on 28-Day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial","volume":"320","author":"Dellinger","year":"2018","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.ccm.2025.11.003_bib128","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2009.856","article-title":"Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial","volume":"301","author":"Cruz","year":"2009","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.ccm.2025.11.003_bib129","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.283.13.1723","article-title":"E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 study investigators","volume":"283","author":"Angus","year":"2000","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ccm.2025.11.003_bib130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJM199102143240701","article-title":"Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group","volume":"324","author":"Ziegler","year":"1991","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-121-1-199407010-00001","article-title":"Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS trial study group","volume":"121","author":"McCloskey","year":"1994","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.003_bib132","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.CCM.0000045564.51812.3F","article-title":"Multicenter evaluation of a human monoclonal antibody to enterobacteriaceae common antigen in patients with Gram-negative sepsis","volume":"31","author":"Albertson","year":"2003","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.ccm.2025.11.003_bib133","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jama.2013.2194","article-title":"Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial","volume":"309","author":"Opal","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ccm.2025.11.003_bib134","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","article-title":"A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis","volume":"38","author":"Rice","year":"2010","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib135","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/01.CCM.0000124870.42312.C4","article-title":"CD14 receptor occupancy in severe sepsis: results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14)","volume":"32","author":"Reinhart","year":"2004","journal-title":"Crit Care Med"},{"issue":"26","key":"10.1016\/j.ccm.2025.11.003_bib136","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM199606273342603","article-title":"Treatment of septic shock with the tumor necrosis factor receptor:fc fusion protein. The soluble TNF receptor sepsis study group","volume":"334","author":"Fisher","year":"1996","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.003_bib137","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00003246-200103000-00006","article-title":"Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients","volume":"29","author":"Abraham","year":"2001","journal-title":"Crit Care Med"},{"issue":"9107","key":"10.1016\/j.ccm.2025.11.003_bib138","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(05)60602-2","article-title":"Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II study group","volume":"351","author":"Abraham","year":"1998","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ccm.2025.11.003_bib139","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.1995.03520360048038","article-title":"Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb sepsis study group","volume":"273","author":"Abraham","year":"1995","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ccm.2025.11.003_bib140","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/00003246-199609000-00002","article-title":"INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International sepsis trial study group","volume":"24","author":"Cohen","year":"1996","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.ccm.2025.11.003_bib141","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1097\/01.CCM.0000145229.59014.6C","article-title":"Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab\u2019)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels","volume":"32","author":"Panacek","year":"2004","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.ccm.2025.11.003_bib142","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","article-title":"Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 receptor antagonist Sepsis investigator group","volume":"25","author":"Opal","year":"1997","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib143","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00003246-199401000-00008","article-title":"Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial","volume":"22","author":"Fisher","year":"1994","journal-title":"Crit Care Med"},{"issue":"23","key":"10.1016\/j.ccm.2025.11.003_bib144","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1401520","article-title":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome","volume":"370","author":"Truwit","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ccm.2025.11.003_bib145","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1164\/rccm.201209-1718OC","article-title":"A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis","volume":"187","author":"Kruger","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.003_bib146","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00003246-199904000-00020","article-title":"Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in sepsis study group","volume":"27","author":"Arons","year":"1999","journal-title":"Crit Care Med"},{"issue":"13","key":"10.1016\/j.ccm.2025.11.003_bib147","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM199703273361303","article-title":"The effects of ibuprofen on the physiology and survival of patients with sepsis. The ibuprofen in sepsis study group","volume":"336","author":"Bernard","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.003_bib148","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.CCM.0000048629.32625.5D","article-title":"Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis","volume":"31","author":"Root","year":"2003","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.003_bib149","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/01.CCM.0B013E318161E480","article-title":"Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock","volume":"36","author":"Stephens","year":"2008","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.ccm.2025.11.003_bib150","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","article-title":"Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial","volume":"180","author":"Meisel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib151","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/CCM.0b013e31822d7bf0","article-title":"A randomized trial of recombinant human GM-CSF for patients with acute lung injury","volume":"40","author":"Paine","year":"2012","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.003_bib152","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archsurg.141.2.150","article-title":"Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial","volume":"141","author":"Orozco","year":"2006","journal-title":"Arch Surg"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.003_bib153","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1164\/rccm.2009005","article-title":"A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction","volume":"166","author":"Presneill","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.003_bib154","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/cc11932","article-title":"The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial","volume":"17","author":"Wu","year":"2013","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib155","doi-asserted-by":"crossref","first-page":"e98960","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.003_bib156","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/CCM.0000000000003685","article-title":"Immune checkpoint inhibition in sepsis: a phase 1b randomized, placebo-controlled, single ascending dose study of antiprogrammed cell death-ligand 1 antibody (BMS-936559)","volume":"47","author":"Hotchkiss","year":"2019","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.ccm.2025.11.003_bib157","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00134-019-05704-z","article-title":"Immune checkpoint inhibition in sepsis: a phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab","volume":"45","author":"Hotchkiss","year":"2019","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.003_bib158","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/SHK.0000000000001443","article-title":"Pharmacokinetics, pharmacodynamics, and safety of nivolumab in patients with sepsis-induced immunosuppression: a multicenter, open-label phase 1\/2 study","volume":"53","author":"Watanabe","year":"2020","journal-title":"Shock"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523125000978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523125000978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:06:00Z","timestamp":1778504760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523125000978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":157,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0272523125000978"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2025.11.003","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunology of Sepsis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2025.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}